A Case Study on HPLC Detection of NOx in Human Plasma Samples

Hypertension continues to be a leading cause of cardiovascular disease, driving the need for innovative therapeutic solutions. Nitrate supplements offer a promising alternative to traditional vasodilators, providing safer, more accessible options for blood pressure management.

This case study highlights the work of Dr. Stephen Baker and Dr. Daniel Kim-Shapiro at Wake Forest University, who used the ENO-30 HPLC system to measure nitric oxide derivatives (NOx) in human plasma. Their research showcases how precise and high-throughput NOx detection can advance understanding of nitrate metabolism and its effects on cardiovascular health.

What You’ll Learn:

• Enhanced throughput for clinical trials.
• Simultaneous nitrate and nitrite detection.
• Insights into personalized hypertension treatment.

For any further questions, please contact us.